Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shapiro

Showing results (1041-1050 of 1,392) with videos related to

Pageof 140
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 18, 2007
Clinical Trial of the Pan-Caspase Inhibitor, IDN-6556, in Human Liver Preservation InjuryE S Baskin-Bey, K Washburn, S Feng, et al.
European Journal of Preventive Cardiology|February 7, 2024
Small dense low-density lipoprotein cholesterol and coronary artery calcification in the Multi-Ethnic Study of AtherosclerosisRishi Rikhi, Christopher L Schaich, George W Hafzalla, et al.
Journal of the National Cancer Institute|April 24, 2024
The association of health-care contact days with physical function and survival in CCTG/AGITG CO.17Arjun Gupta, Christopher J O'Callaghan, Liting Zhu, et al.
Blood|September 24, 2004
The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia BAmy D Shapiro, Jorge Di Paola, Alice Cohen, et al.
International Journal of Obesity (2005)|February 17, 2010
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose studyL J Aronne, S Tonstad, M Moreno, et al.
Critical Care (London, England)|September 4, 2014
Effects of intra-abdominal sepsis on atherosclerosis in miceAta Murat Kaynar, Sachin Yende, Lin Zhu, et al.
Cardiovascular Diabetology|December 3, 2022
Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease preventionXiao-Dong Zhou, Jingjing Cai, Giovanni Targher, et al.
JCO Oncology Practice|March 7, 2023
Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 TrialArjun Gupta, Christopher J O'Callaghan, Liting Zhu, et al.
European Urology Oncology|July 13, 2023
The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic FeaturesE Jason Abel, Viraj A Master, Philippe E Spiess, et al.
Progress in Cardiovascular Diseases|February 19, 2022
Association of participation in Cardiac Rehabilitation with Social Vulnerability Index: The behavioral risk factor surveillance systemSina Kianoush, Mahmoud Al Rifai, Jaideep Patel, et al.
Pageof 140

Showing results (1041-1050 of 1,392) with videos related to

Sort By:
Pageof 140
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 18, 2007
Clinical Trial of the Pan-Caspase Inhibitor, IDN-6556, in Human Liver Preservation InjuryE S Baskin-Bey, K Washburn, S Feng, et al.
European Journal of Preventive Cardiology|February 7, 2024
Small dense low-density lipoprotein cholesterol and coronary artery calcification in the Multi-Ethnic Study of AtherosclerosisRishi Rikhi, Christopher L Schaich, George W Hafzalla, et al.
Journal of the National Cancer Institute|April 24, 2024
The association of health-care contact days with physical function and survival in CCTG/AGITG CO.17Arjun Gupta, Christopher J O'Callaghan, Liting Zhu, et al.
Blood|September 24, 2004
The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia BAmy D Shapiro, Jorge Di Paola, Alice Cohen, et al.
International Journal of Obesity (2005)|February 17, 2010
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose studyL J Aronne, S Tonstad, M Moreno, et al.
Critical Care (London, England)|September 4, 2014
Effects of intra-abdominal sepsis on atherosclerosis in miceAta Murat Kaynar, Sachin Yende, Lin Zhu, et al.
Cardiovascular Diabetology|December 3, 2022
Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease preventionXiao-Dong Zhou, Jingjing Cai, Giovanni Targher, et al.
JCO Oncology Practice|March 7, 2023
Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 TrialArjun Gupta, Christopher J O'Callaghan, Liting Zhu, et al.
European Urology Oncology|July 13, 2023
The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic FeaturesE Jason Abel, Viraj A Master, Philippe E Spiess, et al.
Progress in Cardiovascular Diseases|February 19, 2022
Association of participation in Cardiac Rehabilitation with Social Vulnerability Index: The behavioral risk factor surveillance systemSina Kianoush, Mahmoud Al Rifai, Jaideep Patel, et al.
Pageof 140